Navigation Links
Live vaccines more effective against horse herpes virus

Following the recent deadly outbreak of equine herpes virus at Churchill Downs, home of the Kentucky Derby, a Cornell University virologist says his preliminary research indicates that vaccines containing weakened live viruses, called modified live vaccines (MLV), appear to be more effective in preventing horse herpes than other more widely used vaccines.

"It's important that people know that the MLV has been in use for decades, has proven to be reasonably safe, and in -- my opinion -- it should be the vaccine of choice, at least in non-pregnant animals," said Klaus Osterrieder, associate professor of virology in the College of Veterinary Medicine at Cornell. The college is home to the Animal Health Diagnostic Center, the official regulatory diagnostic laboratory for equine diseases in New York state.

On May 18, two horses stabled at Churchill Downs showed symptoms of the neurological form of equine herpes and were euthanized, leading to concern at the May 22 Preakness Stakes at Pimlico Race Course near Baltimore. In anticipation of the June 11, $1 million Belmont Stakes, the third leg of the Triple Crown, in Belmont, N.Y., the New York Racing Association (NYRA) on May 18 issued travel restrictions for all horses that might have been exposed to equine herpes virus, with special attention paid to those stabled at Churchill Downs since May 1.

In some 90 percent of infected horses, equine herpes virus type 1 (EHV-1) leads to a mild upper respiratory infection with fever, nasal discharge and fatigue for a day or two. The virus can also cause pregnant mares to abort, and in its severest form it can lead to neurological disorders, loss of coordination and even death. The virus is spread mainly by intimate contact between horses. Once infected, a horse carries the virus for the rest of its life in a "latent" (dormant) state. The same symptoms from the initial infection can be reactivated by stress later in life.

Osterrieder will present his n
'"/>

Source:Cornell University News Service


Page: 1 2 3

Related biology news :

1. Designing vaccines by computer
2. Improving the potential of cancer vaccines
3. Report focuses on challenges to unlocking future promise of vaccines
4. Medical experts: US unlikely to have enough vaccines to stop avian flu
5. Plant-derived vaccines safeguard against deadly plague
6. High-dose flu vaccines appear to safely boost immunity in elderly
7. Handling HPV vaccines and screening: The views of 100 authors
8. Protecting virus offers instant flu protection and converts flu infections into their own vaccines
9. Super enzyme may lead way to better tumor vaccines
10. Cellulose nanocrystal research could lead to new vaccines, computer inks
11. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system

Post Your Comments:
(Date:11/19/2009)...ring Harbor, NY A four-year, multi-institutional ...ry (CSHL) scientists culminated today in publicati...Science revealing in unprecedented detail the DNA...s it is commonly called by North American consumer... the most valuable agricultural crop grown in the ...
(Date:11/19/2009)..., WALL, N.J., Nov. 19 B...YI), a leader in wireless public safety and finger...ed that the Special Shareholder Meeting held today...use a quorum was not present. ,, (Logo: http:/... ,, While an impressive 99.3% of the 35 million...
(Date:11/19/2009)... Tenn., Nov. 19, 2009 -- Sustainable farming, init...generations, may also play a role in maintaining a...Department of Energy,s Oak Ridge and Los Alamos na...are exploring the large potential of the earth,s s...that new land-use practices could greatly reduce U...
Breaking Biology News(10 mins):Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 1Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 2Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 3Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 4Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 1Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 2A drug dispensing contact lens 13129 1A drug dispensing contact lens 13129 2
...eleasing methane, a greenhouse gas, at rates that ...y estimated" and acting as a positive feedback to ...lished today in the journal Nature. , Walter,s pro...een accurately quantified. "We realized that our p...portant component of lake emissions - in these bub...
...o a cloudy or damaged cornea are seeing some remar...cial implant that takes the place of the cornea, t...ndow on the world. , The results of operations inv... to receive the device, performed by physicians at...olleague at Johns Hopkins University, are being an...
...the AICR ?the Association for International Cancer...don identify potential targets for drugs that bloc...dies of its kind, Dr Buzz Baum of the UCL Branch o...(LICR) is using the tiny fruit fly, Drosophila, as...s that may impact on the spread of human cancer ce...
Other Biology News:Siberian lakes burp 'time-bomb' greenhouse gas 2Artificial cornea offers better results for infants, some blind patients 2Artificial cornea offers better results for infants, some blind patients 3Artificial cornea offers better results for infants, some blind patients 4Artificial cornea offers better results for infants, some blind patients 5Artificial cornea offers better results for infants, some blind patients 6Using nature's most primitive anti-viral defense system to find new approaches to cancer research 2
(Date:11/18/2009)...at the National Institute of Standards and Technol...nexpensive method for detecting and measuring elus...s, invisible spoilage in food or pesticides distri...od is more sensitive than conventional techniques ... polarlike water molecules, having distinct electr...
(Date:11/18/2009)...RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -...nced today that data from the University of Pennsy... of Sangamo,s zinc finger nuclease (ZFN) based pro...d prematurely disclosed on the internet. ,, Dat...sity of Pennsylvania School of Medicine from a sin...
(Date:11/18/2009)..., NEW YORK, Nov. 18 Reportlinker...s available in its catalogue. ,, Biotechnolog... http://www.reportlinker.com/p0164375/Biotechnolog...source=prnewswire&utm_medium=pr&utm_campai...gy are complex chemical compounds used in a range ...
(Date:11/18/2009)...VT-111 significantly reduces key cardiac enzymes a... presented at American Heart Association 2009 Scie...wire/ - Viron Therapeutics Inc., a biotechnology c...ting protein therapeutics derived from pathogens, ...rial evaluating VT-111 (Serp-1), an anti-inflammat...
Breaking Biology Technology:Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4
... connect employers to candidates with active U.S. ... FORT WORTH, Texas, Sept. 30 onTargetjobs and,Cle...that benefits those,career candidates with an acti...tjobs network of niche career Web sites. The partn...line job postings, advertising, and,candidate resu...
...ept. 30 Syngenta announced a,multi-year agreement...gy,that will enhance the Syngenta technical toolki...will support Syngenta researchers, understanding,o... decisions on crop,traits earlier in the developme...important part of Syngenta,s,focused program to ap...
...Sept. 30 Biotel Inc. (OTC,Bulletin Board: BTEL) a...with net earnings of $666,000, or $0.23 per dilute... to net earnings of $520,000, or $0.19 per share,o...its fourth quarter, the,company reported net earni...venues of $3,187,000. This compares to net earning...
Other Biology Technology:onTargetjobs and ClearedConnections Announce Online Recruitment Partnership 2Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology 2Biotel Announces Record Revenues and Earnings for Fiscal 2008 2
Analog thermal printer, Sony (230V) for DigiDoc-It, MultiDoc-It and ChromaDoc-It Imaging Systems from UVP
Thermal paper, high gloss, 5 rolls (1000 images) from UVP
GeneAmp AccuRT RNA PCR Kit with Controls from Applied Biosystems
...rase is a thermostable DNA polymerase purified fro...the procedures developed by Kaledin (1,2,3) for th... polymerase activity from thermophilic bacteria. A... be achieved with this enzyme. The enzyme has both...
Biology Products: